Overview

Clinical Trial of Teriparatide in Japan

Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the Efficacy and Safety of Teriparatide in Japanese Postmenopausal Women with Osteoporosis.
Phase:
Phase 2
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Teriparatide